| Tissue Specificity | Predominantly expressed in neural tissues, especially in brain. Expression is reduced in low-grade brain tumors and significantly reduced or absent in malignant gliomas. Isoform 1: Expressed in the occipital cortex and hippocampus.higher amounts are observed in the parietal and frontal cortices, putamen, and, particularly, in the temporal neocortex, where it is between 3 and 5 times more abundant than in the hippocampus (at protein level). Expression is absent in the cerebellum. Isoform 3: Abundantly expressed in the occipital cortex and weakly expressed in the hippocampus (at protein level). |
| Post Translational Modifications | Glycosylated. |
| Function | Regulates voltage-gated potassium channels assembled from KCNA1, KCNA4 and KCNAB1. It slows down channel inactivation by precluding channel closure mediated by the KCNAB1 subunit. Ligand for ADAM22 that positively regulates synaptic transmission mediated by AMPA-type glutamate receptors. Plays a role in suppressing the production of MMP1/3 through the phosphatidylinositol 3-kinase/ERK pathway. May play a role in the control of neuroblastoma cell survival. |
| Protein Name | Leucine-Rich Glioma-Inactivated Protein 1Epitempin-1 |
| Database Links | Reactome: R-HSA-5682910 |
| Cellular Localisation | SecretedSynapseCytoplasmIsoform 1: Golgi ApparatusIsoform 2: Endoplasmic Reticulum |
| Alternative Antibody Names | Anti-Leucine-Rich Glioma-Inactivated Protein 1 antibodyAnti-Epitempin-1 antibodyAnti-LGI1 antibodyAnti-EPT antibodyAnti-UNQ775 antibodyAnti-PRO1569 antibody |
Information sourced from Uniprot.org
